We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
The Mission Group Plc | LSE:TMG | London | Ordinary Share | GB00B11FD453 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 23.00 | 22.00 | 24.00 | 23.00 | 23.00 | 23.00 | 96,505 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Advertising Agencies | 182.69M | 9k | 0.0001 | 2,300.00 | 20.93M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/7/2020 08:28 | is this aquisition good | ali47fish | |
21/7/2020 22:15 | Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion covers TMG and the prospects for the Marketing sector. We also chatted about loads of other Stocks and as always a fair bit of general Portfolio Management educational stuff. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 27) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, Cheers, WD @wheeliedealer | thewheeliedealer | |
16/7/2020 09:41 | Edison latest:- | jeff h | |
16/7/2020 08:03 | Pathfindr's revenues of c £750,000 (£49 each)in only a few weeks: I think mid - June was when they were starting to deliver, is impressive. Given BooHoos troubles, I would have thought all factories are going to need something and with secondary outbreaks around the world, this is going to be the case for some time. That is a big market. I don't think I am being outlandish when I say that we are looking at millions in revenue and pretty decent profit here. | bbluesky | |
15/7/2020 17:18 | I moved from WPP to TMG, one for the future. | petewy | |
15/7/2020 16:17 | "..the Board sees no reason why in FY2021, PBT cannot return to the pre-pandemic levels similar to those of FY2019, in a range between GBP9m-GBP10m." Market clearly doesn't buy this, or at least not yet. "To date we have sold over 15,000 (Pathfindr)units with a strong forward order book for the months ahead." Not setting the world on fire but will still keep a watch in here. | sphere25 | |
15/7/2020 14:17 | Having managed their net debt well for years they look fairly resilient but tough ongoing times must surely push this back up again. I agree this statement sounds over optimistic and am concerned that expectations will likely not be met in 2021. Long term I'm on board though. | symbiote | |
15/7/2020 10:18 | Operating expenses isn’t a good metric as that includes advertising spend which is a pass through cost, whereas leasing comes against company profits. Seemed decent enough if somewhat optimistic to me. | dr biotech | |
15/7/2020 09:46 | Returning to 2019 levels but over-quoting the PBT (as far as i could see it was under £9m). So that's not £9-£10m in my book of mathematics. There have also been a gradual rise in SII (I suspect these were incentive options for the BoD?). Looking at 2020 so far I see over 4 million options have been excercised at a price of zero pence per share! Cost savings for closing 2 offices will dent the outstanding long term lease "debt" (pro-rated would be £3m). The saving of 700k though is against total operating expenses of over £160m in 2019, so less than 0.5% | thorpematt | |
15/7/2020 07:47 | A very rose tinted statement, with little explanation. Amongst all the rhetoric about how good they are doing, turnover is down 25%, with a 5.5m turnaround in profits from +3.4 to -2.2m. The outlook that next year could return to 2019 levels fails to recognise, perhaps like most stock markets, that a prolonged recession is almost inevitable. | cb7 | |
03/7/2020 14:57 | Well, I did see a while that Amazon warehouses in the US, were trialing such a device (Pathfindr I don't know), but I woud have thought in many enclosed environments it is a new addition to PPE, even at 1 meter. | bbluesky | |
03/7/2020 07:40 | Big difference between “looking at” and placing the order. It’ll be interesting to see how many they sell. I’ve had these for longer than I can remember, they are not a huge part of my holding and I like to follow them so hope they’d stay independent. | dr biotech | |
01/7/2020 12:59 | No stock at 63 but the market doesn't look interested. Still, glad to have put TMG on the main watchlist. I completely missed (slipping, slipping!) the recent news highlighted here on the Safe Distancing Assistant and one potential customer looking at buying 250,000 units. Don't know how much discount TMG give to the normal price of £49.99 for a larger order like that, but IF there is any progress on this product, this stock could go nuts. Clearly the numbers would be very material to the existing financials and we have all seen how anything Covid-19 related has moved recently, The best bit would be that there would still be a proper business to fall back on rather than a completely speculative play where it's almost all or nothing. Not sure if this does take off, but will be watching closely. | sphere25 | |
01/7/2020 08:41 | CLL bid today. That follows HNT, CHW, CRE. They're all getting taken out. SAA has popped 14%. Wonder if there will be any impact here? | sphere25 | |
14/6/2020 19:55 | Wouldn't have thought so as they issued a trading update on 21st May.Next update should be interims in July. | johndoe23 | |
12/6/2020 10:19 | will it issue an agm statement on monday anyone? | ali47fish | |
05/6/2020 10:25 | ......The bottom line is that the market perception of Mission and the reality of how the business is trading are not aligned. Indeed, the 43 per cent share price discount to net asset value, and the miserly rating of six times last year’s post-tax profits, implies a catastrophic reversal in earnings this year and little hope of recovery thereafter. I would beg to differ, so much so that having initiated coverage at the current price ('Alpha Research: Simon Thompson’s latest bargain buy', 11 Oct 2018), I feel that this year’s de-rating has gone too far. Recovery buy. | davebowler | |
04/6/2020 12:26 | Moved too far for me, well done all that have made the 48-70p ride! Have bought CLL for a month or so, last year July update, previous highs IMO could be revisited given its recent RNS's and Healthcare slant. DYOR naturally and hope you don't mind the biased mention on a board and share sort of related! QS99 | qs99 | |
03/6/2020 16:03 | Its on the way up | forensic | |
03/6/2020 15:38 | Last time ST tipped this it went up to this level then dropped back to 55p... | johndoe23 | |
03/6/2020 14:26 | so thompson says this is a recovery buy- is this good enough to add- i dont see high volumes so i am going to wait an update is in a week's time i think | ali47fish | |
01/6/2020 14:53 | If they are making £20 a unit (guess) that’s going to be substantial. | dr biotech | |
01/6/2020 12:53 | £49.99 each The Safe Distancing Assistant is now in production and can be purchased in the Pathfindr Shop. Orders placed from May 28th onwards will be shipped from June 22nd. For larger orders of 250, 500, 1000, 5000+ we will start to ship from June 22nd, with phased delivery of the full quantity within 2-3 weeks. To manage significant demand for the product, we are taking deposits for larger volumes so customers can secure their place in the order queue. | bbluesky | |
01/6/2020 12:38 | ST mentions Pathfindr and the The Safe Distancing Assistant. CEO claims Pathfindr has been approached with a 250,000 unit enquiry ... | 18bt | |
01/6/2020 12:03 | Simon Thompson Ic update | tole |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions